St. Jude kicks off next-gen renal denervation study; Carmat wins approvals for artificial heart;

 @FierceMedDev: Study: FDA medical device inspections up 47% under Obama. More | Follow @FierceMedDev

 @MarkHFierce: C.R. Bard has settled a DOJ case alleging kickbacks in exchange for use of its prostate cancer treatment. Release | Follow @MarkHFierce

 @DamianFierce: Invacare has cleared the first hurdle to getting past an FDA consent decree. Article | Follow @DamianFierce

> St. Jude Medical ($STJ) has enrolled its first patient in the EnligHTN III study, designed to test the safety and effectiveness of the second-generation EnligHTN renal denervation device. More

> U.K. patients have far worse access to insulin pump treatments than in other European nations, a report concludes. Story

> France's Carmat won approval in four countries to start implanting its artificial heart. Article

> Scientists at Tel Aviv University have come up with a biodegradable implant, combined with "regeneration gel," that helped regenerate new nerves in animal tests. Story

> In two studies, ablation outside the pulmonary vein improved treatment of atrial fibrillation. Report

> Diagnostics company Vermillion ($VRML) has raised $13.2 million in a private placement. Item

> Third Rock Ventures, whose portfolio includes diagnostics and device companies, added a Genzyme veteran and former Eli Lilly executive to its team. Release

Biotech News

 @FierceBiotech:  In case you missed it last week: Henri Termeer rediscovers the 'Genzyme feel' in world of biotech startups. Story | Follow @FierceBiotech

 @JohnCFierce: Astellas chops OSI, Perseid ops in global R&D restructuring. Report | Follow @JohnCFierce

 @RyanMFierce: AbbVie is forking over $70 million upfront in collab with Alvine for PhII drug against Celiac disease. Release | Follow @RyanMFierce

> Third Rock Ventures expands roster with Alnylam's CEO and Genzyme/Sanofi vet. More

> Suspicious lawmakers query FDA's Hamburg on sudden departure of deputy commish. News

Pharma News

 @FiercePharma: Ranbaxy inks record-setting $500M manufacturing settlement with the feds: Report | Follow @FiercePharma

> France slaps Sanofi with $53M fine for 'disparaging' Plavix generics. More

> Merck execs' bogeymen: Animal-rights, disease activists, plus laid-off workers. Story

> AstraZeneca, Astellas among Optimer bidders, Bloomberg sources say. Report

Biotech Research News

 @EmilyMFierce: Compound developed by Salk Institute scientists protects against Alzheimer's-related disease behaviors. Report | Follow @EmilyMFierce

> New therapeutic target found for pancreatic cancer. News

> Gene silencing technique could pave way for new class of drugs. Story

> Hormone reverses heart failure symptoms in mice. Item

> Vaccine stops cocaine from reaching brain in monkeys. Article

Pharma Manufacturing News

> FDA says scale of compounding problem is unclear. Report

> Airborne transit mooted as source of remote drug contaminants. Article

> Ranbaxy pleads guilty in $500M case. Story

> USP opens training center in Ghana to raise standards. Item

> WHO clears way for Sanofi's antimalarial ingredient. More

Suggested Articles

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.

The randomized, blinded study showed statistically significant improvements in assessments of inattention and brain activity.